SODA NIKKA (8158) FY2027 Q1 Earnings Report

Quick View

Executive Summary

In addition to higher revenue and earnings, the operating profit margin improved substantially from the previous year, making the qualitative improvement in the earnings structure the key feature of the quarter. Revenue was ¥18.46B (up +15.2% YoY), Operating Income was ¥0.82B (up +92.8%), Ordinary Income was ¥1.07B (up +75.1%), and Net Income was ¥0.79B (up +119.1%). In addition to higher revenue, lower SG&A expenses as a percentage of revenue enabled Operating Income to expand at a pace substantially exceeding revenue growth, and the Operating Income margin improved to 4.5% from the previous year.

Factors Affecting Earnings

【Revenue】Revenue increased by double digits to ¥18.46B (up +15.2% YoY). By segment, Chemicals, which accounts for 63.7% of the revenue mix, maintained stable growth with revenue of ¥11.76B (up +10.4%), while FunctionalMaterials posted strong growth of ¥5.41B (up +44.4%), serving as the main driver of revenue growth. The revenue mix was Chemicals 63.7% and FunctionalMaterials 29.3%, indicating that dependence on the Chemicals Business remains high.

【Profit and Loss】Gross profit was ¥2.59B (up +13.6%), with the gross margin at 14.0%, a slight decline from 14.2% in the previous year. Meanwhile, SG&A expenses declined to ¥1.77B (¥1.86B in the previous year), and the SG&A ratio improved to 9.6% (11.6% in the previous year), resulting in a substantial increase in Operating Income to ¥0.82B (up +92.8%). Ordinary Income was ¥1.07B (up +75.1%); of ¥0.27B in non-operating income, dividend income accounted for ¥0.26B, contributing to the increase in Ordinary Income. Net Income was ¥0.79B (up +119.1%). Extraordinary income, including a gain on the sale of fixed assets of ¥0.08B, and extraordinary losses of ¥0.02B provided a slight uplift, but their impact was limited. Segment Operating Income increased in both Chemicals, at ¥1.02B (up +21.0%, margin 8.7%), and FunctionalMaterials, at ¥0.36B (up +88.5%, margin 6.7%), indicating results characterized by higher revenue and earnings.

Segment Analysis

Chemicals secured stable growth in both revenue and earnings as the core business, with revenue of ¥11.76B (up +10.4% YoY), Operating Income of ¥1.02B (up +21.0%), and a margin of 8.7% (8.0% in the previous year). FunctionalMaterials recorded revenue of ¥5.41B (up +44.4%), Operating Income of ¥0.36B (up +88.5%), and a margin of 6.7% (5.5% in the previous year), expanding at a pace exceeding the Company-wide rates of both revenue and earnings growth, while also improving its margin. Against combined segment profit of ¥1.47B, ¥0.65B in Company-wide expenses is deducted as an adjustment (¥0.64B in the previous year), and the improvement in segment margins directly translates into an increase in the Company-wide Operating Income margin.

Key Financial Indicators

【Profitability】The Operating Income margin improved from the previous year to 4.5%, while the Net Income margin also increased to 4.3% (2.3% in the previous year). ROE was 2.2% based on quarterly results.【Cash Flow Quality】Accounts receivable and notes receivable totaled ¥41.34B, accounting for 51.8% of total assets, suggesting that the difference from accounts payable of ¥33.06B remains tied up as working capital. Inventories were limited at ¥1.58B, indicating that the amount of funds tied up in inventory is limited.【Investment Efficiency】Investment securities totaled ¥21.28B (26.7% of total assets), an increase of ¥3.57B from ¥17.71B in the previous year, primarily due to an increase of +¥2.43B in the valuation difference on other securities.【Financial Soundness】The Equity Ratio was 45.7%, improving by +2.3pt from 43.4% in the previous year. Short-term safety was favorable, with a current ratio of 137.7% and a quick ratio of 133.4%. Although all interest-bearing debt of ¥1.67B consisted of short-term borrowings, it was sufficiently covered by cash and deposits of ¥7.29B (cash/short-term borrowings of approximately 4.4x). Short-term borrowings declined by ¥0.99B (-37.3%) from the previous year, indicating a more conservative financial structure.

Cash Flow Analysis

Cash and deposits were ¥7.29B, down ¥0.83B from ¥8.12B in the previous year. However, short-term borrowings declined to ¥1.67B from ¥2.66B in the previous year, a reduction of ¥0.99B, suggesting that interest-bearing debt was reduced through the use of cash on hand. While inventories were limited at ¥1.58B and the amount of funds tied up in inventory was limited, the Company has substantial accounts receivable and notes receivable of ¥41.34B and accounts payable of ¥33.06B, creating a structure in which working capital equivalent to the difference between the two can readily become a burden on cash management. Property, plant and equipment was largely unchanged at ¥6.68B (¥6.71B in the previous year), suggesting that no major capital expenditures were undertaken. Investment securities increased by ¥3.57B to ¥21.28B; however, most of this increase resulted from the expansion of valuation differences and differs in nature from new investments involving cash outflows.

Quality of Earnings

In addition to recurring earnings power, non-operating income of ¥0.27B, including dividend income of ¥0.26B (1.5% of revenue), pushed up Ordinary Income and Net Income. Its scale, equivalent to approximately one-third of Net Income of ¥0.79B, should be noted as a feature of the earnings composition. Extraordinary income of ¥0.08B (gain on the sale of fixed assets) and extraordinary losses of ¥0.02B were both small, and their impact on Profit Before Tax of ¥1.13B was limited; they did not materially distort the quality of current-period earnings. Comprehensive Income was ¥3.24B, substantially exceeding Net Income of ¥0.79B, with the primary cause of the difference being the increase of +¥2.43B in the valuation difference on other securities. Because this valuation gain is linked to market conditions, it should be evaluated separately from the Company’s recurring operating earnings power.

Earnings Forecast and Guidance

Q1 progress against the Full-Year earnings forecast was 26.3% for Revenue (¥18.46B/¥70.10B), 31.5% for Operating Income (¥0.82B/¥2.61B), and 34.4% for Ordinary Income (¥1.07B/¥3.11B), indicating that the profit items are progressing at a pace exceeding the progress rate for Revenue. The Full-Year forecasts are Revenue +5.1%, Operating Income +5.2%, and Ordinary Income +6.0% (all YoY), while the Q1 growth rates (Revenue +15.2%, Operating Income +92.8%) substantially exceed these figures. In this quarterly earnings announcement, neither the earnings forecast nor the dividend forecast was revised, and management maintained its current Full-Year plan.

Shareholder Returns

The Full-Year dividend forecast is ¥44, implying a Payout Ratio of approximately 41.0% based on the Full-Year EPS forecast of ¥107.34. The previous year’s actual annual dividend was ¥20, indicating a planned increase in the Full-Year dividend. In addition to the net-cash financial position, with cash and deposits of ¥7.29B versus interest-bearing debt of ¥1.67B, the burden of major capital expenditures is limited, suggesting a reasonable level of capacity to secure funds for dividends. The dividend forecast was not revised in this quarterly earnings announcement.

Risk Factors

1. Delayed cash conversion due to concentration in trade receivables: Accounts receivable and notes receivable totaled ¥41.34B, accounting for 51.8% of total assets, with the difference from accounts payable of ¥33.06B remaining tied up as working capital. Depending on collection trends going forward, the working capital burden may increase during a period of revenue growth.

2. Concentration of revenue in the Chemicals Business: The Chemicals segment accounts for 63.7% of the revenue mix (¥11.76B/¥18.46B), and changes in supply-demand conditions and the competitive pricing environment in this business are likely to have a relatively significant impact on Company-wide performance.

3. Valuation fluctuation risk for investment securities: Investment securities reached ¥21.28B (26.7% of total assets), an increase of ¥3.57B from the previous year. This increase was primarily due to the expansion of valuation differences (+¥2.43B), while deferred tax liabilities also increased by ¥1.195B during the same period. The impact of market fluctuations on net assets and the tax position requires close monitoring.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (trading)

Profitability and Returns

Both the Operating Income margin and Net Income margin are slightly above the industry median.

Growth and Capital Efficiency

The Revenue growth rate substantially exceeds the industry median, indicating a high rate of growth within the industry.

※Source: Compiled by the Company

Key Takeaways from the Earnings Results

1. The improvement in the Operating Income margin from the previous year, driven by discipline in SG&A expenses and an improved segment mix, is noteworthy as a change in the earnings structure. In particular, the strong growth of FunctionalMaterials (Revenue +44.4%, Operating Income +88.5%) is pushing up the Company-wide profit margin.

2. Short-term borrowings were reduced by ¥0.99B from the previous year, progressing the shift toward a net-cash position in which cash and deposits substantially exceed borrowings. From the perspective of financial soundness, the Equity Ratio also improved to 45.7%.

3. On the other hand, the working capital structure in which accounts receivable account for 51.8% of total assets is a monitoring point for capital efficiency during periods of revenue growth. The increase in deferred tax liabilities accompanying the expansion of valuation differences on investment securities should also be noted as a factor affecting fluctuations in net assets.

Theoretical Share Price (Reference Value)

This is a reference range mechanically calculated solely from publicly available data using a residual income model (Ohlson-type model with an explicit 5-year fade period). It is not a forecast of the market share price or a recommendation of any specific investment action.

Sensitivity: ¥1,439–¥1,522 at Cost of Equity ±1%, and ¥1,475–¥1,482 at ω ±0.1.

Notes:

• Because forecast ROE is below the Cost of Equity, the theoretical value is below Book Value Per Share.
• Net assets as of the end of the quarter are used (there is a timing difference from the Full-Year forecast).
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model / Interest Rate Reference Month: 2026-06 / This value does not predict or guarantee the future share price)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, consulting a professional as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2027 Q1 results were materially ahead of the prior-year quarter, led by strong operating leverage and a particularly sharp expansion in the Functional Materials business. Revenue increased 15.2% year on year to ¥18.464bn. Operating income rose 92.8% to ¥822m, substantially outpacing top-line growth. Ordinary income increased 75.1% to ¥1.069bn. Net income attributable to owners of the parent more than doubled, rising 118.8% to ¥793m. The gross margin was 14.0%, down approximately 21bp from 14.3% a year earlier, indicating that procurement and selling spreads remained structurally thin despite profit growth. Conversely, the operating margin improved by approximately 179bp to 4.5% from 2.7%. The net margin expanded by approximately 204bp to 4.3% from 2.3%. This operating-margin improvement was driven by gross profit growth of 13.6% to ¥2.593bn combined with a 7.8% reduction in SG&A expenses to ¥1.771bn. Dividend income of ¥258m accounted for 24.1% of ordinary income and remained a meaningful contributor outside the core trading operations. Profit before tax of ¥1.134bn also included a net extraordinary gain of ¥65m, principally a ¥81m gain on asset sales. Comprehensive income surged to ¥3.239bn, supported by ¥2.446bn of other comprehensive income, including a substantial positive valuation movement in securities. The annualized ROE is 8.7%, supported by a 4.3% net margin, 0.926x annualized asset turnover, and 2.19x financial leverage. Liquidity is adequate, with a 137.7% current ratio and 133.4% quick ratio, while interest-bearing debt is low at 4.4% of capital. The principal balance-sheet issue is not leverage but the large receivables base, equal to 51.8% of total assets and equivalent to 204 annualized days of sales outstanding. Q1 execution is ahead of the full-year plan, with operating-income progress of 31.5% versus a standard 25% seasonal benchmark. The unchanged full-year forecast nevertheless implies a lower operating margin in the remaining quarters than achieved in Q1, making gross-margin preservation, Functional Materials momentum, and working-capital discipline central to the outlook.

Profitability Analysis

The annualized DuPont ROE of 8.7% decomposes into a 4.3% net profit margin, 0.926x asset turnover, and 2.19x financial leverage. The largest favorable change was in profitability rather than balance-sheet leverage: operating income grew 92.8% against 15.2% revenue growth. Gross profit increased ¥310m year on year to ¥2.593bn, while SG&A declined ¥85m to ¥1.771bn. As a result, SG&A as a percentage of revenue fell to 9.6% from 11.6%, creating substantial operating leverage. The gross margin eased to 14.0% from approximately 14.3%, so the margin improvement was not driven by a higher trading spread. The 4.5% EBIT margin remains below the 5% efficiency alert threshold and reflects the inherently low-margin nature of chemicals distribution and trading activities. Interest coverage was exceptionally strong at 82.2x, and the 1.380x interest-burden ratio reflects net non-operating income rather than debt-related pressure. The tax burden was 0.699, broadly normal, with a 30.1% effective tax rate. Dividend income of ¥258m was 1.4% of revenue and supported ordinary income, although it is less directly tied to operating execution than trading margins. The net extraordinary gain of ¥65m added approximately 8.2% of reported net income, modestly enhancing Q1 earnings. Core segment profitability was highest in Chemicals, where segment profit was ¥1.025bn on ¥11.722bn of external revenue, or 8.7% before unallocated corporate costs. Functional Materials generated ¥362m of segment profit on ¥5.013bn of revenue, or 7.2%, and posted the strongest year-on-year profit growth. Other Businesses generated ¥82m of segment profit on ¥1.728bn of revenue, or 4.7%. Unallocated corporate costs were ¥647m, broadly flat year on year, and absorbed 44.0% of aggregate segment profit. The sustainability of the Q1 margin step-up depends on maintaining the lower SG&A intensity and avoiding further gross-margin compression.

Growth Assessment

Revenue growth was broad enough to support the Q1 improvement, but it was concentrated in Functional Materials. Chemicals revenue increased 10.3% year on year to ¥11.722bn, while segment profit rose 21.0% to ¥1.025bn. Functional Materials revenue increased 42.7% to ¥5.013bn and segment profit increased 88.5% to ¥362m, demonstrating strong incremental profitability. Other Businesses revenue declined 8.1% to ¥1.728bn, although segment profit increased from ¥26m to ¥82m. Comparability by segment requires caution because sales previously reported in Other Businesses for Nisshin Co., Ltd. have been included in Chemicals and Functional Materials following the parent-company merger effective 1 April 2026. Therefore, part of the reported segment growth and mix shift reflects presentation changes as well as underlying activity. At the consolidated level, Q1 revenue represents 26.3% of the ¥70.1bn full-year revenue forecast, slightly above the standard 25% progress rate. Operating income represents 31.5% of the ¥2.61bn full-year forecast, 6.5 percentage points above the standard Q1 pace. Ordinary-income progress is 34.4% of forecast, while net-income progress is 32.4%. None of these progress rates exceeds the 10-percentage-point threshold that would indicate a pronounced deviation from normal Q1 seasonality. The unchanged full-year guidance calls for 5.1% revenue growth and 5.2% operating-income growth, materially slower than Q1 reported growth. The FY forecast operating margin is 3.7%, below the 4.5% achieved in Q1, implying management has not embedded the full Q1 operating leverage in its outlook. Revenue sustainability will depend on end-demand conditions in chemical products and functional materials, pricing discipline, and the durability of the post-merger business mix.

Financial Health

Liquidity is sound on reported balance-sheet measures. Current assets of ¥50.675bn exceeded current liabilities of ¥36.810bn, resulting in working capital of ¥13.865bn and a current ratio of 137.7%. The 133.4% quick ratio indicates that liquidity does not depend materially on inventory liquidation. Cash and deposits of ¥7.286bn covered short-term loans of ¥1.668bn by 4.37x. All interest-bearing debt is short-term, producing a 100% short-term debt ratio and a refinancing-risk alert. However, the refinancing risk is moderated by the low absolute debt balance, very strong interest coverage, and substantial cash holdings. Short-term loans decreased ¥993m, or 37.3%, year on year, reducing financial leverage and refinancing exposure. Debt-to-capital is low at 4.4%, and interest-bearing debt is only approximately 4.6% of total equity. The reported 1.19x debt-to-equity ratio should be interpreted alongside the low interest-bearing-debt ratio because it incorporates the company’s sizeable trade and other liabilities rather than indicating debt-funded financial risk alone. Trade payables of ¥33.065bn are the principal current-liability component and broadly finance the receivables-heavy trading cycle. Accounts receivable were ¥41.335bn, exceeding trade payables by ¥8.270bn, reinforcing the importance of collections management. Total equity increased ¥2.699bn year on year to ¥36.473bn, and the capital adequacy ratio improved to 45.7% from 43.4%. Investment securities were ¥21.278bn, or 26.7% of total assets, and their valuation is a material determinant of equity and comprehensive income. Deferred tax liabilities increased to ¥4.665bn, consistent with the higher unrealized valuation reserve on securities. The ¥8.64bn net defined-benefit liability is a long-term obligation to monitor, though it is manageable relative to total equity.

Notable B/S Changes

Short-term loans: -¥0.993bn (-37.3%) to ¥1.668bn — reduced short-term funding dependence and interest burden, although all remaining interest-bearing debt continues to be short-term. Investment securities: +¥3.565bn (+20.1%) to ¥21.278bn — securities now account for 26.7% of total assets, increasing equity sensitivity to market valuations. Deferred tax liabilities: +¥1.195bn (+34.4%) to ¥4.665bn — consistent with the increase in unrealized gains on investment securities and indicates that part of equity appreciation is valuation-driven. Accumulated other comprehensive income: +¥2.413bn (+25.3%) to ¥11.945bn — primarily reflects stronger securities valuation reserves and contributed materially to the increase in total equity.

Cash Flow Quality

Dividend Sustainability

The FY2027 forecast dividend is ¥44 per share. Against forecast EPS of ¥107.34, the implied dividend payout ratio is 41.0%, which is below the 60% sustainability benchmark. Q1 EPS was ¥34.78, meaning the full-year EPS forecast assumes additional earnings generation consistent with the company’s unchanged annual plan. The planned dividend is supported by a solid equity base of ¥36.473bn, low interest-bearing debt of ¥1.668bn, and a 4.37x cash-to-short-term-debt ratio. The payout profile appears balanced rather than aggressive on forecast earnings. Dividend income received by the company of ¥258m also provides a supplementary source of ordinary income, but shareholder distributions should remain principally supported by recurring operating earnings. The key determinant of dividend resilience is preservation of the Q1 operating-profit improvement amid low gross margins and elevated receivables intensity.

Risk Assessment

Business risks include Low-margin trading exposure: the 14.0% gross margin and 4.5% EBIT margin leave earnings sensitive to relatively small changes in chemical-product pricing, procurement costs, logistics expenses, and competitive selling spreads., Functional Materials concentration in quarterly growth: this segment delivered 42.7% revenue growth and 88.5% profit growth, so any normalization in customer demand or mix would have an outsized impact on consolidated profit momentum., Segment comparability risk: the absorption of Nisshin Co., Ltd. changed the allocation of sales from Other Businesses into Chemicals and Functional Materials, complicating interpretation of reported segment growth rates., Investment-market exposure: investment securities represent 26.7% of assets, and securities valuation movements were a major contributor to the ¥2.446bn other comprehensive income gain., Industry-specific chemicals-distribution risk: inventory, customer credit, and price-volatility risks can intensify during abrupt movements in feedstock prices or industrial-production demand..

Financial risks include Receivables concentration is the most material financial risk: trade receivables of ¥41.335bn equal 51.8% of total assets, and annualized DSO is 204 days, well above the 60-day quality-alert threshold., Short-term debt ratio is 100%, creating a contractual refinancing requirement even though the ¥1.668bn debt balance is modest and cash coverage is strong., The balance sheet carries ¥4.665bn of deferred tax liabilities and a ¥11.945bn accumulated other comprehensive income balance, leaving equity partly exposed to market-value changes in securities., Net defined-benefit liability of ¥864m creates a long-duration funding obligation..

Key concerns include The LOW_OPERATING_EFFICIENCY alert is warranted because the 4.5% EBIT margin remains below 5%; Q1 improvement was driven mainly by SG&A leverage while gross margin compressed, so the improvement may be vulnerable if operating costs normalize., The REFINANCING_RISK alert is technically valid because all interest-bearing borrowings mature in the short term; its practical impact is currently contained by 4.37x cash coverage, 82.2x interest coverage, and a 37.3% year-on-year reduction in short-term loans., The HIGH_RECEIVABLE_DAYS alert is material because 204 annualized DSO ties up capital and raises collection and counterparty-risk sensitivity; it is the most important balance-sheet efficiency metric to monitor., The LOW_GROSS_MARGIN alert is structurally relevant because a 14.0% gross margin provides limited protection against adverse procurement costs or price competition, despite the strong Q1 SG&A leverage..

Investment Implications

Key takeaways include Q1 operating income growth of 92.8% materially exceeded 15.2% revenue growth, reflecting a meaningful improvement in SG&A efficiency., Functional Materials was the principal growth engine, while Chemicals remained the largest profit contributor and core business., Q1 operating-income progress of 31.5% is ahead of the 25% seasonal benchmark, whereas unchanged guidance remains relatively conservative versus the quarterly run rate., The capital structure is resilient, with 4.4% debt-to-capital, 45.7% capital adequacy, and strong cash coverage of short-term loans., Receivables intensity and securities-valuation exposure are the principal balance-sheet issues rather than interest-bearing leverage., The forecast ¥44 dividend implies a manageable 41.0% payout ratio based on forecast EPS..

Metrics to watch include Gross margin and EBIT margin, particularly whether the 4.5% Q1 EBIT margin can be maintained while the gross margin is 14.0%., Functional Materials revenue and segment-profit momentum after adjusting for the Nisshin business reclassification., Annualized DSO and the relationship between trade receivables and trade payables., Short-term loan balances, cash coverage, and refinancing terms., Investment-securities valuation movements, accumulated other comprehensive income, and deferred-tax-liability changes., Progress against the ¥70.1bn revenue, ¥2.61bn operating-income, and ¥2.45bn net-income FY2027 forecasts..

Regarding relative positioning, Soda Nikka exhibits stronger-than-typical balance-sheet debt capacity for a trading-oriented distributor, but its profitability profile remains constrained by low gross and operating margins. The Q1 earnings acceleration and 8.7% annualized ROE indicate improving execution, while the unusually long receivables cycle and significant investment-securities exposure differentiate its risk profile from a pure asset-light distributor.